Regulated cell death (RCD) in cancer: key pathways and targeted therapies

F Peng, M Liao, R Qin, S Zhu, C Peng, L Fu… - Signal transduction and …, 2022 - nature.com
Regulated cell death (RCD), also well-known as programmed cell death (PCD), refers to the
form of cell death that can be regulated by a variety of biomacromolecules, which is …

Why is mortalin a potential therapeutic target for cancer?

AR Yoon, R Wadhwa, SC Kaul, CO Yun - Frontiers in cell and …, 2022 - frontiersin.org
Cancer is one of the leading causes of death worldwide, accounting for nearly 10 million
deaths in 2020. Therefore, cancer therapy is a priority research field to explore the biology of …

HSP70s in breast cancer: promoters of tumorigenesis and potential targets/tools for therapy

AE Kabakov, VL Gabai - Cells, 2021 - mdpi.com
The high frequency of breast cancer worldwide and the high mortality among women with
this malignancy are a serious challenge for modern medicine. A deeper understanding of …

Abrogating the interaction between p53 and mortalin (Grp75/HSPA9/mtHsp70) for cancer therapy: the story so far

A Elwakeel - Frontiers in Cell and Developmental Biology, 2022 - frontiersin.org
p53 is a transcription factor that activates the expression of a set of genes that serve as a
critical barrier to oncogenesis. Inactivation of p53 is the most common characteristic in …

Synthetic small molecule modulators of Hsp70 and Hsp40 chaperones as promising anticancer agents

B Nitzsche, M Höpfner, B Biersack - International Journal of Molecular …, 2023 - mdpi.com
A class of chaperones dubbed heat shock protein 70 (Hsp70) possesses high relevance in
cancer diseases due to its cooperative activity with the well-established anticancer target …

Identification of an imidazopyridine-based compound as an oral selective estrogen receptor degrader for breast cancer therapy

M Pan, V Solozobova, NC Kuznik, N Jung… - Cancer Research …, 2023 - AACR
The pro-oncogenic activities of estrogen receptor alpha (ERα) drive breast cancer
pathogenesis. Endocrine therapies that impair the production of estrogen or the action of the …

Transcriptomics analysis reveals distinct mechanism of breast cancer stem cells regulation in mammospheres from MCF-7 and T47D cells

A Hermawan, H Putri, N Fatimah, HH Prasetio - Heliyon, 2024 - cell.com
Luminal A breast cancer, constituting 70% of breast cancer cases, presents a challenge due
to the development of resistance and recurrence caused by breast cancer stem cells …

[HTML][HTML] Synthetic and natural inhibitors of mortalin for cancer therapy

S Kaushal, S Gupta, S Shefrin, DS Vora, SC Kaul… - Cancers, 2024 - mdpi.com
Simple Summary Mortalin is a heat shock protein 70 stress chaperone family member with
variable subcellular localization in normal and cancer cells. It is an essential protein with …

Mixtures of Three Mortaparibs with Enhanced Anticancer, Anti-Migration, and Antistress Activities: Molecular Characterization in p53-Null Cancer Cells

R Wadhwa, S Yang, HN Meidinna, AN Sari… - Cancers, 2024 - mdpi.com
Simple Summary The Hsp70 family stress chaperone mortalin plays an important role in
carcinogenesis and hence has emerged as a candidate target for cancer drug development …

Identification of a new member of Mortaparib class of inhibitors that target mortalin and PARP1

HN Meidinna, S Shefrin, AN Sari, H Zhang… - Frontiers in Cell and …, 2022 - frontiersin.org
Mortalin, a heat shock family protein enriched in cancer cells, is known to inactivate tumor
suppressor protein p53. Abrogation of mortalin-p53 interaction and reactivation of p53 has …